Active — Not RecruitingNot Applicable

Treatment of Intrabony Defect in Patient With Periodontitis Stage III by Using I-PRF and Xenograft

Egypt20 participantsStarted 2025-02-17

Plain-language summary

Evaluate of the injectable platelet rich fibrin (I-PRF) with xenograft in Intrabony defects of Periodontitis patient stage III versus Xenograft alone.

Who can participate

Age range30 Years – 55 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Patient should have localized Periodontitis stage III grade B with pocket depth ≥ 6mm; indicated for periodontal surgery
✓. Patient's agreement to the surgical procedure and clinical trial.
✓. Age ranged between 30-55 years old.
✓. Intrabony defects with depth ≥3mm.
✓. Free from any systemic conditions and no previous drug affect bone metabolism

Exclusion criteria

✕. Smoking.
✕. Pregnant women.
✕. Patients in variation in anatomical landmarks.
✕. Patients with psychological problems.
✕. Patients with abnormal habits.

What they're measuring

Radiographic parameters

Timeframe: 6 months after treatment

Trial details

NCT IDNCT07261878

SponsorAl-Azhar University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-02-18

View on ClinicalTrials.gov More Intrabony Defect trials